Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 937817, 7 pages
http://dx.doi.org/10.1155/2014/937817
Clinical Study

Directly-Observed Intermittent Therapy versus Unsupervised Daily Regimen during the Intensive Phase of Antituberculosis Therapy in HIV Infected Patients

Department of Infectious Diseases, Bathalapalli Rural Development Trust Hospital, Kadiri Road, Bathalapalli, Anantapur, Andhra Pradesh 515661, India

Received 25 February 2014; Revised 23 May 2014; Accepted 26 May 2014; Published 11 June 2014

Academic Editor: Anete Trajman

Copyright © 2014 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Global tuberculosis control,” 2012, http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf.
  2. S. D. Lawn, A. D. Harries, G. Meintjes, H. Getahun, D. V. Havlir, and R. Wood, “Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa,” AIDS, vol. 26, no. 17, pp. 2121–2133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, “Global tuberculosis control,” 2011, http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf.
  4. WHO, UNICEF, and UNAIDS, “Progress report 2011: Global HIV/AIDS response,” 2011, http://www.who.int/hiv/pub/progress_report2011/en/.
  5. WHO, Treatment of Tuberculosis: Guidelines for National Programmes, 3rd edition, 2003, WHO/CDS/TB/2003.313, http://whqlibdoc.who.int/hq/2003/WHO_CDS_TB_2003.313_eng.pdf.
  6. S. Tripathy, A. Anand, V. Inamdar et al., “Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP short course regimen in Pune, India,” Indian Journal of Medical Research, vol. 133, no. 5, pp. 521–528, 2011. View at Google Scholar · View at Scopus
  7. G. Alvarez-Uria, P. K. Naik, R. Pakam, L. Bachu, and M. Midde, “Natural history and factors associated with early and delayed mortality in HIV-infected patients treated of tuberculosis under directly observed treatment short-course strategy: a prospective cohort study in India,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 502012, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Swaminathan, G. Narendran, P. Venkatesan et al., “Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial,” The American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, pp. 743–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. E. Bliven-Sizemore, J. L. Johnson, S. Goldberg, W. J. Burman, M. E. Villarino, and R. E. Chaisson, “Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment,” International Journal of Tuberculosis and Lung Disease, vol. 16, no. 4, pp. 473–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Ahmad Khan, J. Minion, A. Al-Motairi, A. Benedetti, A. D. Harries, and D. Menzies, “An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with hiv infection,” Clinical Infectious Diseases, vol. 55, no. 8, pp. 1154–1163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents (n.d.), “Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America,” 2013, http://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-oi-prevention-and-treatment-guidelines/0.
  12. A. L. Pozniak, K. M. Coyne, R. F. Miller et al., “British HIV Association guidelines for the treatment of TB/HIV coinfection 2011,” HIV Medicine, vol. 12, no. 9, pp. 517–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. World Health Organization, Treatment of Tuberculosis: Guidelines for National Programmes, 4th edition, 2009, http://www.who.int/tb/publications/tb_treatmentguidelines/en/.
  14. A. Kumar, A. M. V. Kumar, D. Gupta et al., “Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues,” International Journal of Tuberculosis and Lung Disease, vol. 16, no. 5, pp. 573–578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. “Comparing Daily vs Intermittent Regimen of ATT in HIV with Pulmonary Tuberculosis,” 2013, http://clinicaltrials.gov/show/NCT00933790.
  16. “Office of The Registrar General & Census Commissioner, India,” Census of India, 2011.
  17. National AIDS Control Organisation, “HIV Sentinel Surveillance 2010-11. A Technical Brief,” 2012, http://naco.gov.in/upload/Surveillance/Reports%20&%20Publication/HSS%202010-11_Technical%20Brief_30%20Nov%2012.pdf.
  18. G. Alvarez-Uria, M. Midde, R. Pakam, and P. K. Naik, “Gender differences, routes of transmission, sociodemographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India,” Infectious Disease Reports, vol. 4, no. 1, pp. 66–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Alvarez-Uria, M. Midde, R. Pakam, S. Kannan, L. Bachu, and P. K. Naik, “Factors associated with late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource-limited setting: data from an HIV cohort study in India,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 293795, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Alvarez-Uria, M. Midde, R. Pakam, and P. K. Naik, “Diagnostic and prognostic value of serum albumin for tuberculosis in HIV infected patients eligible for antiretroviral therapy: datafrom an HIV cohort study in India,” Bioimpacts, vol. 3, pp. 123–128, 2013. View at Publisher · View at Google Scholar
  21. G. Alvarez-Uria, R. Pakam, M. Midde, and P. K. Naik, “Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low- and middle-income countries,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2013, Article ID 384805, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Alvarez-Uria, M. Midde, R. Pakam, L. Bachu, and P. K. Naik, “Effect of formula feeding and breastfeeding on child growth, infant mortality, and hiv transmission in children born to HIV-infected pregnant women who received triple antiretroviral therapy in a resource-limited setting: data from an HIV cohort study in India,” ISRN Pediatrics, vol. 2012, Article ID 763591, 9 pages, 2012. View at Publisher · View at Google Scholar
  23. G. Alvarez-Uria, M. Midde, R. Pakam, and P. K. Naik, “Initial antituberculous regimen with better drug penetration into cerebrospinal fluid reduces mortality in HIV infected patients with tuberculous meningitis: data from an HIV observational cohort study,” Tuberculosis Research and Treatment, vol. 2013, Article ID 242604, 7 pages, 2013. View at Publisher · View at Google Scholar
  24. WHO, Treatment of Tuberculosis: Guidelines for National Programmes, 4th edition, 2010, http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf.
  25. L. Tarantino, A. Giorgio, G. de Stefano, N. Farella, A. Perrotta, and F. Esposito, “Disseminated mycobacterial infection in AIDS patients: abdominal US features and value of fine-needle aspiration biopsy of lymph nodes and spleen,” Abdominal Imaging, vol. 28, no. 5, pp. 602–608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Sharma, D. Smith-Rohrberg, M. Tahir, A. Mohan, and A. Seith, “Radiological manifestations of splenic tuberculosis: a 23-patient case series from India,” Indian Journal of Medical Research, vol. 125, pp. 669–678, 2007. View at Google Scholar
  27. Ministry of Health and Family Welfare India, “Technical and operational guideline for tuberculosis control,” 2005, http://www.tbcindia.nic.in/pdfs/Technical%20&%20Operational%20guidelines%20for%20TB%20Control.pdf.
  28. I. N. Gang, K. Sen, and M. S. Yun, Caste, Ethnicity, and Poverty in Rural India, IZA, 2002.
  29. G. Alvarez-Uria, M. Midde, and P. K. Naik, “Socio-demographic risk factors associated with HIV infection in patients seeking medical advice in a rural hospital of India,” Journal of Public Health Research, vol. 1, no. 1, p. e14, 2012. View at Publisher · View at Google Scholar
  30. G. Ridgeway, D. McCaffrey, A. Morral, L. Burgette, and B. A. Griffin, Toolkit for Weighting and Analysis of Nonequivalent Groups: A Tutorial for the Twang Package, RAND Corporation, 2013.
  31. D. F. Mccaffrey, B. A. Griffin, D. Almirall, M. E. Slaughter, R. Ramchand, and L. F. Burgette, “A tutorial on propensity score estimation for multiple treatments using generalized boosted models,” Statistics in Medicine, vol. 32, no. 19, pp. 3388–3414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. P. C. Austin, “The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments,” Statistics in Medicine, vol. 33, no. 7, pp. 1242–1258, 2014. View at Publisher · View at Google Scholar
  33. F. E. Harrell Jr., R. M. Califf, D. B. Pryor, K. L. Lee, and R. A. Rosati, “Evaluating the yield of medical tests,” Journal of the American Medical Association, vol. 247, no. 18, pp. 2543–2546, 1982. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Royston, “Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables,” Stata Journal, vol. 9, no. 3, pp. 466–477, 2009. View at Google Scholar · View at Scopus
  35. V. Coviello and M. Boggess, “Cumulative incidence estimation in the presence of competing risks,” Stata Journal, vol. 4, pp. 103–112, 2004. View at Google Scholar
  36. M. A. Cleves, W. W. Gould, and R. G. Gutierrez, An Introduction to Survival Analysis Using Stata, StataCorp, 2008.
  37. Y. Jain, “India should introduce daily drug treatment for tuberculosis,” British Medical Journal, vol. 347, article f6769, 2013. View at Publisher · View at Google Scholar
  38. J. G. Pasipanodya and T. Gumbo, “A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients,” Clinical Infectious Diseases, vol. 57, no. 1, pp. 21–31, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. N. Paramasivan and P. Venkataraman, “Drug resistance in tuberculosis in India,” Indian Journal of Medical Research, vol. 120, no. 4, pp. 377–386, 2004. View at Google Scholar · View at Scopus
  40. D. Menzies, A. Benedetti, A. Paydar et al., “Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis,” PLoS Medicine, vol. 6, no. 9, Article ID e1000150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. G. R. Babu and R. Laxminarayan, “The unsurprising story of MDR-TB resistance in India,” Tuberculosis, vol. 92, no. 4, pp. 301–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Heinze and P. Jüni, “An overview of the objectives of and the approaches to propensity score analyses,” European Heart Journal, vol. 32, pp. 1704–1708, 2011. View at Publisher · View at Google Scholar
  43. A. S. Albanna, B. M. Smith, D. Cowan, and D. Menzies, “Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis,” European Respiratory Journal, vol. 42, pp. 721–732, 2013. View at Publisher · View at Google Scholar